Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition
The conference calls that follow a company's earnings report are rarely eventful. Usually, a few executives make a statement summarizing the performance of the business and then analysts ask questions. Occasionally, a comment will give shareholders insight into what the leadership team is really thinking.
Fulgent Genetics' (NASDAQ: FLGT) CEO Ming Hsieh made one of these on the company's fourth quarter call in March. He mentioned the potential for an acquisition to expand the company's diagnostic and screening capabilities. Further, he specifically called out a desire to open up new markets in Asia and Europe. With those two pieces of information, let's explore a few of the companies Fulgent Genetics might buy.
Image source: Getty Images.
Source Fool.com
